Amgen’s Scientific Advisory Boards were developed for external scientific review of R&D activities and to assist Amgen management in its responsibility to make significant scientific judgments related to R&D activities and portfolio.

The Scientific Advisory Network is co-chaired by Dr. Elliott Sigal and Dr. David Baltimore. Membership is comprised of David M. Reese, Amgen’s Executive Vice President, Research and Development and external scientific advisors forming Scientific Advisory Boards from the following areas: